+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
G-Protein Coupled Receptors Market - Global Forecast 2026-2032- Product Image
G-Protein Coupled Receptors Market - Global Forecast 2026-2032- Product Image
New

G-Protein Coupled Receptors Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887241
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The G-Protein Coupled Receptors Market is evolving as innovations in science and collaborative approaches redefine drug discovery pathways. Senior leaders require a consolidated, forward-looking analysis to position GPCR program priorities competitively in this complex sector.

Market Snapshot: G-Protein Coupled Receptors Market Growth

The G-Protein Coupled Receptors Market advanced from USD 4.23 billion in 2025 to USD 4.58 billion in 2026 and is forecast to achieve USD 8.15 billion by 2032, representing a CAGR of 9.79%. Sustained growth is driven by rapid progress in structural biology, computational modeling, and a shift toward biomarker-led program designs. As cross-sector collaborations become more prevalent, competitive advantages are increasingly forged by those able to integrate emerging translational strategies and harness regional opportunities in manufacturing and innovation.

Scope & Segmentation of the GPCR Market

  • Receptor Classes: Includes Class A rhodopsin receptors (covering amino acid, chemokine, and peptide receptors); Class B secretin; Class C metabotropic glutamate; Class F frizzled/taste 2; and orphan receptors. This spectrum facilitates varying drug target strategies.
  • Therapeutic Focus Areas: Addresses cardiovascular, CNS, metabolic, inflammatory, gastrointestinal, oncology (with coverage of breast, lung, colorectal, leukemia, prostate), respiratory, and pain therapeutic domains, each with distinct translational priorities.
  • Development Applications: Encompasses drug discovery, preclinical development, diagnostics, and all phases of clinical trials. Companion diagnostics and adaptive trials play increasing roles in expediting program milestones.
  • End-User Profiles: Targets pharmaceutical and biotech companies, contract research organizations, diagnostic laboratories, and academic or research institutes, leveraging specialized platforms and services to meet diverse development goals.
  • Key Regions: Encompasses the Americas (noted for innovation clusters and strong capital access), Europe, Middle East & Africa (offering diverse regulatory approaches and collaborative trial networks), and Asia-Pacific (characterized by expanding manufacturing and cost-efficient clinical operations).
  • Enabling Technologies: Features advancements in structural biology, cryo-EM, computational modeling, high-throughput ligand screening, AI-driven discovery, and the integration of real-world evidence.

Key Takeaways: Strategic Imperatives Shaping the GPCR Landscape

  • Advances in cryo-electron microscopy and computational platforms are expanding the horizon for viable receptor targets in drug development.
  • Early utilization of precision biomarkers and companion diagnostics streamlines clinical progress and aligns development with evolving regulatory requirements.
  • Robust partnerships among biopharma, contract research organizations, and technology suppliers accelerate the translation of validated targets into clinical testing.
  • Diversification across drug modalities—such as small molecules, peptides, biologics, and advanced delivery systems—enables risk-balanced portfolios addressing multiple therapeutic needs.
  • Tailored approaches help match the right receptor classes with the highest-impact disease areas, focusing resources on the most promising patient segments.
  • Operational resilience, including proactive supplier management and scenario planning, remains essential for maintaining project timelines and adapting to external risks.

Tariff Impact on GPCR Supply Chains and Operations

Shifting tariff and trade policies are adding complexity to the procurement and operations landscape. Rising costs for reagents, instrumentation, and outsourced services are prompting market participants to:

  • Evaluate new suppliers to reduce import-related cost exposure.
  • Accelerate inventory procurement and localize sourcing to enhance supply chain control.
  • Adjust clinical operations tactics—including site selection and logistics—to prevent bottlenecks linked to tariffs and manage rising input costs.
  • Increase reshoring and consolidate partnerships with vendors capable of absorbing tariff-associated expenses.

Methodology & Data Sources

This report applies a multi-source methodology integrating scholarly review, case study synthesis, and direct interviews with clinical, scientific, and operations experts. Validation of findings draws on peer-reviewed literature, benchmarking of assay outcomes, expert interviews, and analysis of trends in regional supply chains and regulatory frameworks. Clear documentation of assumptions and cross-verification of data underpin insight reliability.

Why This Report Matters for Senior Leaders

  • Delivers actionable insight across technology, translation, and commercialization to guide program prioritization and strengthen strategic positioning.
  • Provides a direct link between market segmentation and the evolving needs of research, operations, and procurement to support informed corporate and investment decisions.
  • Enables risk-optimized planning to help anticipate and respond effectively to challenges in clinical operations, regulatory requirements, and sourcing strategy.

Conclusion

The G-Protein Coupled Receptors Market is experiencing significant transformation, underpinned by scientific innovation and new models of operational collaboration. Senior decision-makers who integrate agile planning and cross-functional strategic alignment will maximize success in advancing GPCR pipeline programs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. G-Protein Coupled Receptors Market, by Receptor Class
8.1. Class A Rhodopsin
8.1.1. Amino Acid Receptors
8.1.2. Chemokine Receptors
8.1.3. Lipid Receptors
8.1.4. Monoamine Receptors
8.1.5. Opsin Receptors
8.1.6. Peptide Receptors
8.2. Class B Secretin
8.3. Class C Metabotropic Glutamate
8.4. Class F Frizzled/Taste 2
8.5. Orphan Receptors
9. G-Protein Coupled Receptors Market, by Therapeutic Area
9.1. Cardiovascular Diseases
9.2. Cns Disorders
9.3. Gastrointestinal Disorders
9.4. Inflammation
9.5. Metabolic Disorders
9.6. Oncology
9.6.1. Breast Cancer
9.6.2. Colorectal Cancer
9.6.3. Leukemia
9.6.4. Lung Cancer
9.6.5. Prostate Cancer
9.7. Pain Management
9.8. Respiratory Disorders
10. G-Protein Coupled Receptors Market, by Application
10.1. Clinical Trials
10.1.1. Phase I
10.1.2. Phase II
10.1.3. Phase III
10.2. Diagnostics
10.3. Drug Discovery
10.4. Preclinical Development
11. G-Protein Coupled Receptors Market, by End User
11.1. Academic And Research Institutes
11.2. Contract Research Organizations
11.3. Diagnostic Laboratories
11.4. Pharmaceutical And Biotech Companies
12. G-Protein Coupled Receptors Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. G-Protein Coupled Receptors Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. G-Protein Coupled Receptors Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States G-Protein Coupled Receptors Market
16. China G-Protein Coupled Receptors Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abalone Bio, Inc.
17.6. Abcam PLC
17.7. Addex Therapeutics
17.8. Becton, Dickinson and Company
17.9. BioInvenu,Inc.
17.10. Cisbio Bioassays SAS
17.11. Confo Therapeutics
17.12. Corning Incorporated
17.13. Crinetics Pharmaceuticals, Inc.
17.14. Domain Therapeutics SA
17.15. Enzo Life Sciences, Inc.
17.16. Escient Pharmaceuticals
17.17. Eurofins Scientific SE
17.18. Merck KGaA
17.19. Molecular Devices, LLC
17.20. OKYO Pharma, Limited
17.21. Orion Biotechnology
17.22. OSE Immunotherapeutics
17.23. PerkinElmer Inc.
17.24. Promega Corporation
17.25. QIAGEN GmbH
17.26. Septerna
17.27. Sosei Group Corporation
17.28. Tectonic Therapeutic
17.29. Teon Therapeutics, Inc.
17.30. Thermo Fisher Scientific Inc.
17.31. WuXi AppTec
List of Figures
FIGURE 1. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY AMINO ACID RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY AMINO ACID RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY AMINO ACID RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CHEMOKINE RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CHEMOKINE RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CHEMOKINE RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIPID RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIPID RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIPID RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY MONOAMINE RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY MONOAMINE RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY MONOAMINE RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY OPSIN RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY OPSIN RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY OPSIN RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PEPTIDE RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PEPTIDE RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PEPTIDE RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS B SECRETIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS B SECRETIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS B SECRETIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS C METABOTROPIC GLUTAMATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS C METABOTROPIC GLUTAMATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS C METABOTROPIC GLUTAMATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS F FRIZZLED/TASTE 2, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS F FRIZZLED/TASTE 2, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS F FRIZZLED/TASTE 2, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ORPHAN RECEPTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ORPHAN RECEPTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ORPHAN RECEPTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 150. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 151. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 165. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 166. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 167. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 182. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 183. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 184. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 185. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 187. ASEAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 190. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 191. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 192. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 193. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 195. GCC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 206. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 207. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 208. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 209. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 211. BRICS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 214. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 215. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 216. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 217. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 219. G7 G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 222. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 223. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 224. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 225. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 227. NATO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 238. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2032 (USD MILLION)
TABLE 239. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2032 (USD MILLION)
TABLE 240. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 241. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 242. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 244. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this G-Protein Coupled Receptors market report include:
  • Abalone Bio, Inc.
  • Abcam PLC
  • Addex Therapeutics
  • Becton, Dickinson and Company
  • BioInvenu,Inc.
  • Cisbio Bioassays SAS
  • Confo Therapeutics
  • Corning Incorporated
  • Crinetics Pharmaceuticals, Inc.
  • Domain Therapeutics SA
  • Enzo Life Sciences, Inc.
  • Escient Pharmaceuticals
  • Eurofins Scientific SE
  • Merck KGaA
  • Molecular Devices, LLC
  • OKYO Pharma, Limited
  • Orion Biotechnology
  • OSE Immunotherapeutics
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Septerna
  • Sosei Group Corporation
  • Tectonic Therapeutic
  • Teon Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.58 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.15 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

G-Protein Coupled Receptors: Market Share, and Growth Analysis by Product Type (Small Molecule Drugs, Biologics), Application, End User, Technology - Product Image

G-Protein Coupled Receptors: Market Share, and Growth Analysis by Product Type (Small Molecule Drugs, Biologics), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report by Product (Cell Lines, Detection Kits), Application (Cancer Research, CNS Research), Assay, and Region with Growth Forecasts, 2025-2030 - Product Image

G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report by Product (Cell Lines, Detection Kits), Application (Cancer Research, CNS Research), Assay, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
G-Protein Coupled Receptors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

G-Protein Coupled Receptors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 227 Pages
  • Global
From
G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
G-Protein Coupled Receptors Market 2025-2033 - Product Image

G-Protein Coupled Receptors Market 2025-2033

  • Report
  • 141 Pages
  • Global
From

About the G Protein Coupled Receptors Market

G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics. Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs. Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.